Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study
Objectives There is limited research on real-world effectiveness of BBIBP-CorV Sinopharm COVID-19 vaccine. This study evaluated real-world effectiveness of Sinopharm vaccine in Sri Lanka by assessing absolute vaccine efficacy.Design and setting A retrospective test-negative case-control study was co...
Saved in:
| Main Authors: | Dileepa Senajith Ediriweera, Shamila Thivanshi De Silva, Wathsala Wimalasena, Manjula Kariyawasam, Gihan Kosinna, Gayan Bogoda, Sumudu Senaratne, Kanchana Rathnayake, Inosha Weerarathna, Ranjan Premaratna, Prasanna Gunasena |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/11/e090341.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy
by: Sedigheh Hantoushzadeh, et al.
Published: (2023-06-01) -
False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19
by: Jeel Moya-Salazar, et al.
Published: (2025-08-01) -
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers
by: Alexis Hipólito García, et al.
Published: (2025-06-01) -
Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV: a cohort study
by: Shahin Soltani, et al.
Published: (2025-02-01) -
Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.
by: Chandima Jeewandara, et al.
Published: (2022-01-01)